Tasly Pharmaceutical (SHA:600535) posted net profit attributable to shareholders of 370.2 million yuan for the first quarter of 2026, up 18% from 314.3 million yuan a year earlier, according to an April 24 filing on the Shanghai Stock Exchange.
Earnings per share came in at 0.2478 yuan, compared with 0.2104 yuan in the prior-year period.
Revenue rose 5.4% year on year to 2.16 billion yuan from 2.05 billion yuan.
Tasly's shares rose nearly 3% in recent trade.
Chifeng Jilong Gold Mining (SHA:600988, HKG:6693) recorded a 104% rise in attributable profit in the first quarter of 2025 to 988.2 million yuan from 483.4 million yuan in the year-ago period, according to a Friday Hong Kong bourse filing.The miner's earnings per share jumped to 0.52 yuan from 0.29 yuan in the corresponding period of the previous fiscal year.Operating income increased 48% to 3.55 billion yuan from 2.41 billion yuan a year prior.The firm attributed the positive performance to the optimization of production organization and operational management, allowing the firm to benefit from a year-over-year rise in goldselling price.
Jiayuan Services (HKG:1153) completed the placing of 60.5 million shares to two investors at HK$0.25 apiece to raise net proceeds of HK$14.6 million, according to a Friday Hong Kong bourse filing.The shares represent approximately 9% of the real estate developer's enlarged issued share capital.The firm will use proceeds for general working capital, as well as for the settlement of outstanding payables.
BOCOM International (HKG:3329) unit Preferred Investment Management acquired $9 million of certain bonds for $9.1 million from the over-the-counter market on Wednesday, according to a Friday Hong Kong bourse filing.The bonds will be issued by Sumitomo Mitsui Trust Bank and listed on the Singapore Exchange.The company purchased the bonds for investment purposes.